Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Combination With Standard of Care in Advanced Soft Tissue Sarcoma
NCT07291297Phase 2Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in soft tissue sarcoma (STS), sponsored by Wake Forest University Health Sciences. Started Mar 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07291297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07291297.